期刊文献+

PSD-95结构域PDZ1与腺病毒穿梭载体重组体的构建

Construction of recombinant pAdTrack-CMV-PDZ1
下载PDF
导出
摘要 目的构建突触后致密物质-95(PSD-95)结构域PDZ1腺病毒重组体。方法以异硫酸氢胍-酚-氯仿一步法提取的总RNA为模板,采用反转录PCR(RT-PCR)法获得PDZ1的cDNA;与腺病毒穿梭载体用T4DNA连接酶连接;连接产物转化大肠杆菌JM109进行筛选、序列测定。结果①提取到未降解的总RNA;②经RT-PCR得到了PDZ1的cDNA;③酶切鉴定能观察到PDZ1和pAdTrack-CMV两条带;④PDZ1测序图谱与文献报道完全一致。结论获得了含目的基因PDZ1的腺病毒穿梭载体重组体。 Objective To construct recombinant pAdTrack- CMV - PDZ1. Methods Using the total RNA extracted from fresh rat hippocampns as template, the cDNA of PDZ1 was amplified by RT - PCR; the cDNA obtained was subsequently cloned into the shuttle vector pAdTrack-CMV (CLONTECH), and then, the sequence of the product was determined. Results ① Total RNA was obtained. ②The cDNA of PDZ1 was amplified by RT - PCR. ③The recombinant was found containing two bands of pAdTrack - CMV/PDZ1 by restriction enzyme digestion. ④The sequence of cloned PDZ1 was identical with that report- ed in GenBank. Conclusion Recombinant of pAdTrack- CMV- PDZ1 is obtained.
出处 《徐州医学院学报》 CAS 2005年第6期485-488,共4页 Acta Academiae Medicinae Xuzhou
基金 国家自然科学基金资助项目(30330190)
关键词 PDZ1 反转录PCR 腺病毒穿梭载体 序列测定 PDZ1 RT- PCR pAdTrack- CMV sequencing
  • 相关文献

参考文献11

  • 1Kennedy MB. Signal transduction molecules at the glutamatergic postsynaptic membrane[J].Brain Res Brain Res Rev,1998,26(2-3):243-257.
  • 2Hata Y, Takai Y. Roles of postsynaptic density-95/synapse-associated protein 90 and its interacting proteins in the organization of synapses[J].Cell Mol Life Sci,1999,56(5-6):461-472.
  • 3Savinainen A. Garcia EP, Dorow D, et al.Kainate receptor activation induces mixed lineage kinase-mediated cellular signaling cascades via post-synaptic density protein 95[J].J Biol Chem,2001,276(14):11382-11386.
  • 4Whitmaksh AJ, Cavanagh J, Tournier C, et al.A mammalian scaffold complex that selectively mediates MAP kinase activation[J].Science,1998,281(5383):1671-1674.
  • 5Yuan J, Yankner BA.Apoptosis in the nervous system[J].Nature,2000,407(6805):802-809.
  • 6Wang LH, Besirli CG, Johnson EM Jr.Mixed-lineage kinases:a target for the prevention of neurodegeneration[J].Annu Rev Pharmacol Toxicol,2004,44:451-474.
  • 7Bennett BL, Sasaki DT, Murray BW, et al.SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase[J].Proc Natl Acad Sci USA,2001,98(24):13681-13686.
  • 8Guan QH, Pei DS, Zhang QG, et al. The neuroprotective action of SP600125, a new inhibitor of JNK, on transient brain ischemia/reperfusion-induced neuronal death in rat hippocampal CA1 via nuclear and non-nuclear pathways[J].Brain Res,2005,1035(1):51-59.
  • 9PAN J, Zhang QG, Zhang GY.The neuroprotective effects of K252a through inhibiting MLK3/MKK7/JNK3 signaling pathway on ischemic brain injury in rat hippocampal CA1 region[J].Neuroscience,2005,131(1):147-159.
  • 10Barr RK. Kendrick TS, Bogoyevitch MA, et al.Identification of the critical features of a small peptide inhibitor of JNK activity[J].J Biol Chem,2002,277(13):10987-10997.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部